Abstract
Although expression of liver fatty acid binding protein (L-FABP) modulates cell growth, it is not known if L-FABP also alters cell morphology and differentiation. Therefore, pluripotent embryonic stem cells were transfected with cDNA encoding L-FABP and a series of clones expressing increasing levels of L-FABP were isolated. Untransfected ES cells, as well as ES cells transfected only with empty vector, spontaneously differentiated from rounded adipocyte-like to fibroblast-like morphology, concomitant with marked reduction in expression of stage-specific embryonic antigen (SSEA-1). These changes in morphology and expression of SSEA-1 were greatest in ES cell clones expressing L-FABP above a threshold level. Immunofluorescence confocal microscopy revealed that L-FABP was primarily localized in a diffuse-cytosolic pattern along with a lesser degree of punctate L-FABP expression in the nucleus. Nuclear localization of L-FABP was preferentially increased in clones expressing higherlevels of L-FABP. In summary, L-FABP expression altered ES cell morphology and expression of SSEA-1. Taken together with the fact that L-FABP was detected in the nucleus, these data suggested that L-FABP may play a more direct, heretofore unknown, role in regulating ES cell differentiation by acting in the nucleus as well as cytoplasm.
Similar content being viewed by others
References
Kurtz A, Spitzer E, Zschiesche W, Wellstein A, Grosse R: Local control of mammary gland differentiation: Mammary derived growth inhibitor and pleitrophin. Biochem Soc Symp 63: 51–59, 1998
Sorof S: Modulation of mitogenesis by liver fatty acid binding protein. Cancer Metastasis Rev 13: 317–336, 1994
Mandrup S, Lane MD: Minireview: Regulating adipogenesis. J Biol Chem 272: 5367–5370, 1997
Borchers T, Hohoff C, Buhlmann C, Spener F: Heart-type fatty acid binding protein - involvement in growth inhibition and differentiation. Prost Leukot Essen Fatty Acids 57: 77–84, 1997
Binas B, Spitzer E, Zschiesche W, Erdmann R, Kurtz A, Muller T, Niemann C, Blenau W, Grosse R: Hormonal induction of functional differentiation and mammary derived growth inhibitor expression in cultured mouse mammary gland explants. In Vitro Cell Dev Biol 29A: 625–634, 1992
Zschiesche W, Kleine AH, Spitzer E, Veerkamp JH, Glatz JF: Histochemical localization of heart-type fatty-acid binding protein in human and murine tissues. Histochem Cell Biol 103: 147–156, 1995
Bernlohr DA, Simpson MA, Hertzel AV, Banaszak L: Intracellular lipid binding proteins and their genes. Annu Rev Nutr 17: 277–303, 1997
McArthur MJ, Atshaves BP, Frolov A, Foxworth WD, Kier AB, Schroeder F: Cellular uptake and intracellular trafficking of long chain fatty acids. J Lipid Res 40: 1371–1383, 1999
Yang Y, Spitzer E, Kenney N, Zschiesche W, Li M, Kromminga A, Muller T, Spener F, Lezius A, Veerkamp JH, Smith GH, Salomon DS, Grosse R: Members of the fatty acid binding protein family are differentiation factors for the mammary gland. J Cell Biol 127: 1097–1109, 1994
Maatman RG, van de Westerlo EM, Van Kuppevelt TH, Veerkamp JH: Molecular identification of the liver-and the heart-type fatty acid-binding proteins in human and rat kidney. Use of the reverse transcriptase polymerase chain reaction. Biochem J 288: 285–290, 1992
Mangelsdorf DJ, Evans RM: The RXR heterodimers and orphan receptors. Cell 83: 841–850, 1995
Hertz R, Magenheim J, Berman I, Bar-Tana J: Fatty acyl-CoA thioesters are ligands of hepatic nuclear factor-4. Lett Nature 392: 512–516, 1998
Edwards PA, Ericsson J: Signaling molecules derived from the cholesterol biosynthetic pathway: Mechanisms of action and possible roles in human disease. Curr Opin Lipidol 9: 433–440, 1998
Kliewer SA, Sundseth SS, Jones SA, Brown PJ, Wisely GB, Koble CS, Devchand P, Wahli W, Willson TM, Lenhard JM, Lehmann JM: Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors α and γ. Proc Natl Acad Sci USA 94: 4318–4323, 1997
Raman N, Black PN, DiRusso CC: Characterization of the fatty acid responsive transcription factor FadR biochemical and genetic analyses of native conformation and functional domains. J Biol Chem 272: 30645–30646, 1997
Ellinghaus P, Wolfrum C, Assmann G, Spener F, Seedorf U: Phytanic acid activates the peroxisome proliferator-activated receptor alpha (PPARα) in sterol carrier protein-2-/sterol carrier protein x-deficient mice. J Biol Chem 274: 2766–2772, 1999
Frolov AA, Schroeder F: Time-resolved fluorescence of intestinal and liver fatty acid binding proteins: Role of fatty acyl CoA and fatty acid. Biochemistry 36: 505–517, 1997
Peeters RA, in’ t Groen MA, de Moel MP, van Moerkerk HT, Veerkamp JH: The binding affinity of fatty acid-binding proteins from human, pig and rat liver for different fluorescent fatty acids and other ligands. Int J Biochem 21: 407–418, 1989
Rolf B, Oudenampsen-Kruger E, Borchers T, Faergeman NJ, Knudsen J, Lezius A, Spener F: Analysis of the ligand binding properties of recombinant bovine liver-type fatty acid binding protein. Biochim Biophys Acta 1259: 245–253, 1995
Miller KR, Cistola DP: Titration calorimetry as a binding assay for lipid-binding proteins. Mol Cell Biochem 123: 29–37, 1993
Nemecz G, Jefferson JR, Schroeder F: Polyene fatty acid interactions with recombinant intestinal and liver fatty acid binding proteins. J Biol Chem 266: 17112–17123, 1991
Kaikaus RM, Chan WK, Ortiz de Montellano PR, Bass NM: Mechanisms of regulation of liver fatty acid-binding protein [review]. Mol Cell Biochem 123: 93–100, 1993
Khan SH, Sorof S: Liver fatty acid-binding protein: Specific mediator of the mitogenesis induced by two classes of carcinogenic peroxisome proliferators. Proc Natl Acad Sci USA 91: 848–851, 1994
Frolov A, Miller K, Billheimer JT, Cho T-C, Schroeder F: Lipid specificity and location of the sterol carrier protein-2 fatty acid binding site: A fluorescence displacement and energy transfer study. Lipids 32: 1201–1209, 1997
Seedorf U, Raabe M, Ellinghaus P, Kannenberg F, Fobker M, Engel T, Denis S, Wouters F, Wirtz KWA, Wanders RJA, Maeda N, Assmann G: Defective peroxisomal catabolism of branched fatty acyl coenzyme A in mice lacking the sterol carrier protein-2/sterol carrier protein-x gene function. Genes Dev 12: 1189–1201, 1998
Wolfrum C, Ellinghaus P, Fobker M, Seedorf U, Assmann G, Borchers T, Spener F: Phytanic acid is ligand and transcriptional activator of murine liver fatty acid binding protein. J Lipid Res 40: 708–714, 1999
Raza H, Pongubala JR, Sorof S: Specific high affinity binding of lipoxygenase metabolites of arachidonic acid by liver fatty acid binding protein. Biochem Biophys Res Commun 161: 448–455, 1989
Ek BA, Cistola DP, Hamilton JA, Kaduce TL, Spector AA: Fatty acid binding proteins reduced 15-lipoxygenase-induced oxygenation of linoleic acid and arachidonic acid. Biochim Biophys Acta 1346: 75–85, 1997
Frolov A, Cho TH, Billheimer JT, Schroeder F: Sterol carrier protein-2, a new fatty acyl coenzyme A-binding protein. J Biol Chem 271: 31878–31884, 1996
Spiegelman BM, Choy L, Hotamisligil GS, Graves RA, Tontonoz P: Regulation of adipocyte gene expression in differentiation and syndromes of obesity/diabetes [review]. J Biol Chem 268: 6823–6826, 1993
Forman BM, Chen J, Evans RM: Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta. Proc Natl Acad Sci 94: 4312–4317, 1999
Vanden Heuvel JP, Peroxisome proliferator-activated receptors: A critical link among fatty acids, gene expression and carcinogenesis. J Nutr 129: 575S–580S, 1999
Borchers T, Spener F: Fatty acid binding proteins. In: D. Hoekstra (ed). Current Topics in Membranes. Academic Press Inc., Orlando, FL, 1994, pp 261–294
Jiang G, Sladek FM: The DNA binding domain of hepatocyte nuclear factor 4 alpha mediates cooperative, specific binding to DNA and heterodimerization with retinoid X receptor alpha. J Biol Chem 272: 1218–1225, 1997
Jefferson JR, Powell DM, Rymaszewski Z, Kukowska-Latallo J, Schroeder F: Altered membrane structure in transfected mouse L-Cell fibroblasts expressing rat liver fatty acid-binding protein. J Biol Chem 265: 11062–11068, 1990
Atshaves BP, Petrescu A, Starodub O, Roths J, Kier AB, Schroeder F: Expression and intracellular processing of the 58 kDa sterol carrier protein 2/3-oxoacyl-CoA thiolase in transfected mouse L-cell fibroblasts. J Lipid Res 40: 610–622, 1999
Wiles MV: Embryonic stem cell differentiation in vitro. Meth Enzymol 225: 900–918, 1993
Abbondanzo SJ, Gadi I, Stewart CL: Derivation of embryonic stem cell lines. Meth Enzymol 225: 803–820, 1993
Atshaves BP, Foxworth WB, Frolov AA, Roths JB, Kier AB, Oetama BK, Piedrahita JA, Schroeder F: Cellular differentiation and I-FABP protein expression modulate fatty acid uptake and diffusion. Am J Physiol 274: C633–C644, 1998
Strickland S, Mahdavi V: The induction of differentiation in teratocarcinoma stem cells by retinoic acid. Cell 15: 393–403, 1978
Starodub O, Jolly CA, Atshaves BP, Roths JB, Murphy EJ, Kier AB, Schroeder F: Sterol carrier protein-2 immunolocalization in endoplasmic reticulum and stimulation of phospholipid formation. Am J Physiol 279: C1259–C1269, 2000
Schroeder F, Frolov A, Starodub O, Russell W, Atshaves BP, Petrescu A, Huang H, Gallegos A, McIntosh A, Tahotna D, Russell D, Billheimer JT, Baum CL, Kier AB: Pro-sterol carrier protein-2: Role of the N-terminal presequence in structure, function, and peroxisomal targeting. J Biol Chem 275: 25547–25555, 2000
Shapiro HM: In: H.M. Shapiro (ed). Practical Flow Cytometry, 3rd edn. John Wiley & Sons Inc., New York, 1995, pp 230–239
Solter D, Knowles BB: Monoclonal antibody defining a stage-specific mouse embryonic antigen (SSEA-1). Proc Natl Acad Sci 75: 5565–5569, 1978
Prows DR, Murphy EJ, Schroeder F: Intestinal and liver fatty acid binding proteins differentially affect fatty acid uptake and esterification in L-Cells. Lipids 30: 907–910, 1995
Schroeder F, Jefferson JR, Powell D, Incerpi S, Woodford JK, Colles SM, Myers-Payne S, Emge T, Hubbell T, Moncecchi D, Prows DR, Heyliger CE: Expression of rat L-FABP in mouse fibroblasts: Role in fat absorption. Mol Cell Biochem 123: 73–83, 1993
Murphy EJ, Prows DR, Jefferson JR, Schroeder F: Liver fatty acid binding protein expression in transfected fibroblasts stimulates fatty acid uptake and metabolism. Biochim Biophys Acta 1301: 191–198, 1996
Wolfrum C, Buhlman C, Rolf B, Borchers T, Spener F: Variation of liver fatty acid binding protein content in the human hepatoma cell line HepG2 by peroxisome proliferators and antisense RNA affects the rate of fatty acid uptake. Biochim Biophys Acta 1437: 194–201, 1999
Murphy EJ: L-FABP and I-FABP expression increase NBD-stearate uptake and cytoplasmic diffusion in L-cells. Am J Physiol 38: G244–G249, 1998
Weisiger RA: Cytoplasmic transport of lipids: Role of binding proteins. Comp Biochem Physiol 115B: 319–331, 1996
Luxon BA, Weisiger RA: Sex differences in intracellular fatty acid transport: Role of cytoplasmic binding proteins. Am J Phys 265: G831–G841, 1993
Weisiger RA: When is a carrier not a membrane carrier? The cytoplasmic transfer of amphipathic molecules. Hepatology 24: 1288–1295, 1998
Moya-Camarena SY, Vanden Heuvel JP, Belury MA: Conjugated linoleic acid activates peroxisome proliferator-activated receptors alpha and beta subtypes but does not induce hepatic peroxisome proliferation in Sprague-Dawley rats. Biochim Biophys Acta 1436: 331–342, 1999
Kohler M, Haller H, Hartmann E: Nuclear protein transport pathways. Exp Nephrol 7: 290–294, 1999
Gorlich D, Mattaj IW: Nucleocytoplasmic transport. Science 271: 1513–1518, 1996
Fahimi HD, Voelkl A, Vincent SH, Muller-Eberhard U: Localization of the heme-binding protein in the cytoplasm and of a heme-binding protein-like immunoreactive protein in the nucleus of rat liver parenchymal cells: Immunocytochemical evidence of the subcellular distribution corroborated by radioimmunoassay and immunoblotting. Hepatology 11: 859–865, 1990
Vinores SA, Churey JJ, Haller JM, Schnabel SJ, Custer RP, Sorof S: Normal liver chromatin contains a firmly bound and larger protein related to the principal cytosolic target polypeptide of a hepatic carcinogen. Proc Natl Acad Sci 81: 2092–2096, 1984
Bordewick U, Heese M, Borchers T, Robenek H, Spener F: Compartmentation of hepatic fatty-acid-binding protein in liver cells and its effect on microsomal phosphatidic acid biosynthesis. Biol Chem Hoppe-Seyler 370: 229–238, 1989
Binas B, Gusterson B, Wallace R, Clark AJ: Epithelial proliferation and differentiation in the mammary gland do not correlate with cFABP gene expression during early pregnancy. Dev Genet 17: 167–175, 1995
Binas B, Danneberg H, McWhir J, Mullins L, Clark AJ: Requirement for the heart-type fatty acid binding protein in cardiac fatty acid utilization. FASEB J 13: 805–812, 1999
Schaap FG, Binas B, Danneberg H, Van der Vusse GJ, Glatz JF: Impaired long-chain fatty acid utilization by cardiac myocytes isolated from mice lacking the heart type fatty acid binding protein gene. Circ Res 85: 329–337, 1999
Hotamisligl GS, Johnson RS, Distel RJ, Ellis RF, Papaioannou VE, Spiegelman BM: Uncoupling of obesity from insulin resistance through a targeted mutation in aP2, the adipocyte fatty acid binding protein. Science 274: 1377–1379, 1996
Coe NR, Simpson MA, Bernlohr DA: Targeted disruption of the adipocyte lipid binding protein (aP2 protein) gene impairs fat cell lipolysis and increased cellular fatty acid levels. J Lipid Res 40: 967–972, 1999
Seedorf U: Functional analysis of sterol carrier protein-2 (SCP2) in SCP2 knockout mouse. In: T.Y. Chang, D.A. Freeman (eds). Intracellular Cholesterol Trafficking. Kluwer Academic Publishers, Boston, 1998, pp 233–252
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Schroeder, F., Atshaves, B.P., Starodub, O. et al. Expression of liver fatty acid binding protein alters growth and differentiation of embryonic stem cells. Mol Cell Biochem 219, 127–138 (2001). https://doi.org/10.1023/A:1010851130136
Issue Date:
DOI: https://doi.org/10.1023/A:1010851130136